Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex

Journal of the Neurological Sciences

Volumn 312, Issue 1-2, 2012, Pages 52-56

  Loukaides, Panayiotis ^a   Schiza, Natasa ^b   Pettingill, Philippa ^c   Palazis, Lakis ^a   Vounou, Emmelia ^a   Vincent, Angela ^c   Kleopa, Kleopas A ^b  

^a LIMASSOL GENERAL HOSPITAL   (Cyprus)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Caspr2; Contactin 2 Tag 1; Lgi1; Morvan's syndrome; Neuromyotonia; VGKC

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; AXONIN 1; CARBAMAZEPINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN ANTIBODY; PROTEIN CASPR2; PROTEIN LGI1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

AGED; AGITATION; ANTIBIOTIC THERAPY; ANTIGENICITY; ANXIETY; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOPNEUMONIA; BRONCHOSPASM; CASE REPORT; CELL ASSAY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONFUSION; CRANIAL NERVE; DETERIORATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DYSARTHRIA; DYSESTHESIA; DYSPNEA; ELECTROMYOGRAPHY; EXTUBATION; FASCICULATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERHIDROSIS; IMMUNOHISTOCHEMISTRY; INSOMNIA; INTENSIVE CARE; INTENSIVE CARE UNIT; IRRITABILITY; MALE; MEMORY DISORDER; MORVAN SYNDROME; MYALGIA; MYOKYMIA; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PERIPHERAL NERVE; PLEOCYTOSIS; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESTLESSNESS; SLEEP DISORDER; TACHYPNEA; TREATMENT DURATION; VISUAL HALLUCINATION;

AGED; AUTOANTIBODIES; CONTACTIN 2; HUMANS; ISAACS SYNDROME; MALE; MEMBRANE PROTEINS; MYOKYMIA; NERVE TISSUE PROTEINS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEINS;

EID: 84155164263     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.08.024     Document Type: Article

References (20)

1. J. Newsom-Davis, and K.R. Mills Immunological associations of acquired neuromyotonia (Isaacs syndrome) - report of five cases and literature review Brain 116 Part 2 1993 453 469 (Pubitemid 23104058)
2. I. Hart, P. Maddison, J. Newsom-Davis, A. Vincent, and K. Mills Phenotypic variants of autoimmune peripheral nerve hyperexcitability Brain 125 2002 1887 1895
3. P.A. Barber, N.E. Anderson, and A. Vincent Morvan's syndrome associated with voltage-gated K+ channel antibodies Neurology 54 2000 771 772 (Pubitemid 30082963)
4. R. Liguori, A. Vincent, L. Clover, P. Avoni, G. Plazzi, and P. Cortelli Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels Brain 124 2001 2417 2426 (Pubitemid 33134931)
5. C. Rinaldi, C.V. Russo, A. Filla, G. De Michele, and E. Marano Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome Neurol Sci 30 2009 237 239
6. W.N. Löscher, J. Wanschitz, K. Reiners, and S. Quasthoff Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies Muscle Nerve 30 2004 157 163 (Pubitemid 38982219)
7. S.R. Irani, S. Alexander, P. Waters, K.A. Kleopa, P. Pettingill, and L. Zuliani Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 133 2010 2734 2748
8. K.A. Kleopa, L. Elman, B. Lang, A. Vincent, and S.S. Scherer Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations Brain 129 2006 1570 1584 (Pubitemid 43999388)
9. A. Vincent Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems J Clin Immunol Suppl 1 2010 S97 S102
10. B.K. Bajaj, and S. Shrestha An interesting case report of Morvan's syndrome from the Indian subcontinent Neurol India 55 2007 67 69
11. E. Lee, R. Maselli, W. Ellis, and M. Agius Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma J Neurol Neurosurg Psychiatry 65 1998 857 862 (Pubitemid 128710425)
12. A. Madrid, A. Gil-Peralta, E. Gil-Néciga, J.R. González, and S. Jarrín Morvan's fibrillary chorea: remission after plasmapheresis J Neurol 243 1996 350 353 (Pubitemid 26099507)
13. M. Halbach, V. Homberg, and H.J. Freund Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody J Neurol 234 1987 433 436
14. K.A. Josephs, M.H. Silber, R.D. Fealey, T.B. Nippoldt, R.G. Auger, and S. Vernino Neurophysiologic studies in Morvan syndrome J Clin Neurophysiol 21 2004 440 445 (Pubitemid 40076284)
15. J. Díaz-Manera, R. Rojas-García, E. Gallardo, C. Juárez, A. Martínez-Domeño, and S. Martínez- Ramírez Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome Nat Clin Pract Neurol 3 2007 405 410 (Pubitemid 47040330)
16. J.R. Cornelius, S.J. Pittock, A. McKeon, V.A. Lennon, P.A. Aston, and K.A. Josephs Sleep manifestations of voltage-gated potassium channel complex autoimmunity Arch Neurol 68 2011 733 738
17. M.D. Geschwind, K.M. Tan, V.A. Lennon, and R.F. Barajas Jr. Haman A, Klein CJ and others. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease Arch Neurol 65 2008 1341 1346
18. + channels Neuron 24 1999 1037 1047 (Pubitemid 30017681)
19. M. Traka, L. Goutebroze, N. Denisenko, M. Bessa, A. Nifli, and S. Havaki Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers J Cell Biol 162 2003 1161 1172 (Pubitemid 37174197)
20. S. Poliak, D. Salomon, H. Elhanany, H. Sabanay, B. Kiernan, and L. Pevny Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1 J Cell Biol 162 2003 1149 1160 (Pubitemid 37174196)